nodes	percent_of_prediction	percent_of_DWPC	metapath
Bopindolol—ADRB3—polycystic ovary syndrome	0.618	0.724	CbGaD
Bopindolol—ADRB2—polycystic ovary syndrome	0.235	0.275	CbGaD
Bopindolol—Bupranolol—ADRB3—polycystic ovary syndrome	0.00134	0.194	CrCbGaD
Bopindolol—Carvedilol—ADRA1D—polycystic ovary syndrome	0.000707	0.102	CrCbGaD
Bopindolol—Carvedilol—ADRB3—polycystic ovary syndrome	0.000635	0.0917	CrCbGaD
Bopindolol—Carvedilol—ADRA1B—polycystic ovary syndrome	0.000603	0.0871	CrCbGaD
Bopindolol—Carteolol—ADRB2—polycystic ovary syndrome	0.0006	0.0867	CrCbGaD
Bopindolol—Bupranolol—ADRB2—polycystic ovary syndrome	0.00051	0.0737	CrCbGaD
Bopindolol—Propranolol—ADRB3—polycystic ovary syndrome	0.000483	0.0697	CrCbGaD
Bopindolol—Carvedilol—VEGFA—polycystic ovary syndrome	0.000429	0.0619	CrCbGaD
Bopindolol—Mebendazole—CYP1A1—polycystic ovary syndrome	0.00042	0.0606	CrCbGaD
Bopindolol—Carvedilol—ADRA1A—polycystic ovary syndrome	0.000406	0.0586	CrCbGaD
Bopindolol—Carvedilol—ADRB2—polycystic ovary syndrome	0.000241	0.0349	CrCbGaD
Bopindolol—Carvedilol—CYP1A1—polycystic ovary syndrome	0.000207	0.0299	CrCbGaD
Bopindolol—Propranolol—ADRB2—polycystic ovary syndrome	0.000184	0.0265	CrCbGaD
Bopindolol—Propranolol—CYP1A1—polycystic ovary syndrome	0.000157	0.0227	CrCbGaD
Bopindolol—ADRB3—Signaling Pathways—FGF18—polycystic ovary syndrome	3.91e-05	0.00028	CbGpPWpGaD
Bopindolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	3.91e-05	0.00028	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—PTAFR—polycystic ovary syndrome	3.88e-05	0.000278	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—RBP4—polycystic ovary syndrome	3.88e-05	0.000278	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	3.83e-05	0.000274	CbGpPWpGaD
Bopindolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	3.82e-05	0.000274	CbGpPWpGaD
Bopindolol—ADRB3—Signaling by GPCR—GNAS—polycystic ovary syndrome	3.82e-05	0.000274	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—FSHR—polycystic ovary syndrome	3.81e-05	0.000273	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—PTAFR—polycystic ovary syndrome	3.8e-05	0.000272	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—ADRA1D—polycystic ovary syndrome	3.77e-05	0.00027	CbGpPWpGaD
Bopindolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	3.74e-05	0.000268	CbGpPWpGaD
Bopindolol—HTR1B—GPCR ligand binding—POMC—polycystic ovary syndrome	3.74e-05	0.000268	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—PTAFR—polycystic ovary syndrome	3.71e-05	0.000266	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—GHRL—polycystic ovary syndrome	3.71e-05	0.000266	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—ADRA1D—polycystic ovary syndrome	3.69e-05	0.000264	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—ADRA1B—polycystic ovary syndrome	3.67e-05	0.000263	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—YAP1—polycystic ovary syndrome	3.62e-05	0.00026	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—ADRA1D—polycystic ovary syndrome	3.61e-05	0.000258	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—ADRA1B—polycystic ovary syndrome	3.59e-05	0.000257	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—RACGAP1—polycystic ovary syndrome	3.59e-05	0.000257	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—INHBB—polycystic ovary syndrome	3.57e-05	0.000256	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—GAB1—polycystic ovary syndrome	3.57e-05	0.000256	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—ADRA1B—polycystic ovary syndrome	3.51e-05	0.000251	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—INHBB—polycystic ovary syndrome	3.5e-05	0.000251	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—ADRA1A—polycystic ovary syndrome	3.49e-05	0.00025	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—INHBB—polycystic ovary syndrome	3.42e-05	0.000245	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—INSR—polycystic ovary syndrome	3.42e-05	0.000245	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—FST—polycystic ovary syndrome	3.4e-05	0.000244	CbGpPWpGaD
Bopindolol—HTR1B—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	3.38e-05	0.000242	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—ADRB3—polycystic ovary syndrome	3.36e-05	0.000241	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—PDE3B—polycystic ovary syndrome	3.34e-05	0.000239	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—LHB—polycystic ovary syndrome	3.32e-05	0.000238	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—PDE3B—polycystic ovary syndrome	3.26e-05	0.000234	CbGpPWpGaD
Bopindolol—ADRB1—GPCR downstream signaling—GHRL—polycystic ovary syndrome	3.25e-05	0.000233	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—AKR1C3—polycystic ovary syndrome	3.25e-05	0.000233	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—GNRH1—polycystic ovary syndrome	3.24e-05	0.000233	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—TNRC6B—polycystic ovary syndrome	3.19e-05	0.000229	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—PDE3B—polycystic ovary syndrome	3.19e-05	0.000229	CbGpPWpGaD
Bopindolol—ADRB2—GPCR downstream signaling—GHRL—polycystic ovary syndrome	3.18e-05	0.000228	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—PGR—polycystic ovary syndrome	3.16e-05	0.000227	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—AKR1C1—polycystic ovary syndrome	3.14e-05	0.000225	CbGpPWpGaD
Bopindolol—HTR1B—GPCR downstream signaling—GNAS—polycystic ovary syndrome	3.13e-05	0.000225	CbGpPWpGaD
Bopindolol—HTR1A—GPCR downstream signaling—GHRL—polycystic ovary syndrome	3.11e-05	0.000223	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—SCT—polycystic ovary syndrome	3.11e-05	0.000223	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—ADRB2—polycystic ovary syndrome	3.07e-05	0.00022	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—FSHR—polycystic ovary syndrome	3.04e-05	0.000218	CbGpPWpGaD
Bopindolol—ADRB1—GPCR ligand binding—POMC—polycystic ovary syndrome	2.97e-05	0.000213	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—FSHR—polycystic ovary syndrome	2.97e-05	0.000213	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—MTNR1B—polycystic ovary syndrome	2.97e-05	0.000213	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—GHRL—polycystic ovary syndrome	2.95e-05	0.000212	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—PLAT—polycystic ovary syndrome	2.94e-05	0.000211	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—GHRL—polycystic ovary syndrome	2.94e-05	0.000211	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—FGF18—polycystic ovary syndrome	2.92e-05	0.000209	CbGpPWpGaD
Bopindolol—ADRB2—GPCR ligand binding—POMC—polycystic ovary syndrome	2.91e-05	0.000209	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—FSHR—polycystic ovary syndrome	2.91e-05	0.000208	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—RBP4—polycystic ovary syndrome	2.89e-05	0.000207	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—GHRL—polycystic ovary syndrome	2.89e-05	0.000207	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	2.86e-05	0.000205	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—GNAS—polycystic ovary syndrome	2.85e-05	0.000204	CbGpPWpGaD
Bopindolol—HTR1A—GPCR ligand binding—POMC—polycystic ovary syndrome	2.85e-05	0.000204	CbGpPWpGaD
Bopindolol—HTR1A—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	2.83e-05	0.000203	CbGpPWpGaD
Bopindolol—ADRB3—GPCR downstream signaling—POMC—polycystic ovary syndrome	2.83e-05	0.000203	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—GHRL—polycystic ovary syndrome	2.83e-05	0.000203	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—ATF1—polycystic ovary syndrome	2.8e-05	0.000201	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—RACGAP1—polycystic ovary syndrome	2.79e-05	0.0002	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	2.78e-05	0.000199	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—TCF7L2—polycystic ovary syndrome	2.74e-05	0.000196	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—RACGAP1—polycystic ovary syndrome	2.73e-05	0.000196	CbGpPWpGaD
Bopindolol—ADRB3—GPCR downstream signaling—AKT2—polycystic ovary syndrome	2.72e-05	0.000195	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—ADRA1A—polycystic ovary syndrome	2.72e-05	0.000195	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—FST—polycystic ovary syndrome	2.71e-05	0.000194	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—YAP1—polycystic ovary syndrome	2.7e-05	0.000193	CbGpPWpGaD
Bopindolol—ADRB1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	2.69e-05	0.000193	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—ADRB3—polycystic ovary syndrome	2.67e-05	0.000192	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—GAB1—polycystic ovary syndrome	2.66e-05	0.000191	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—ADRA1A—polycystic ovary syndrome	2.66e-05	0.000191	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—FST—polycystic ovary syndrome	2.65e-05	0.00019	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—LHB—polycystic ovary syndrome	2.64e-05	0.000189	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—ADRB3—polycystic ovary syndrome	2.62e-05	0.000188	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—FST—polycystic ovary syndrome	2.59e-05	0.000186	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—NGFR—polycystic ovary syndrome	2.59e-05	0.000186	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—LHB—polycystic ovary syndrome	2.59e-05	0.000185	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—GNRH1—polycystic ovary syndrome	2.58e-05	0.000185	CbGpPWpGaD
Bopindolol—HTR1A—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	2.58e-05	0.000185	CbGpPWpGaD
Bopindolol—ADRB3—Signaling by GPCR—POMC—polycystic ovary syndrome	2.57e-05	0.000184	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—PRL—polycystic ovary syndrome	2.57e-05	0.000184	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—ADRB3—polycystic ovary syndrome	2.56e-05	0.000183	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—INSR—polycystic ovary syndrome	2.55e-05	0.000182	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—LHB—polycystic ovary syndrome	2.53e-05	0.000181	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—GNRH1—polycystic ovary syndrome	2.53e-05	0.000181	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	2.5e-05	0.000179	CbGpPWpGaD
Bopindolol—ADRB1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	2.5e-05	0.000179	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—SCT—polycystic ovary syndrome	2.48e-05	0.000178	CbGpPWpGaD
Bopindolol—ADRB3—Signaling by GPCR—AKT2—polycystic ovary syndrome	2.47e-05	0.000177	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—GNRH1—polycystic ovary syndrome	2.47e-05	0.000177	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—AKR1C1—polycystic ovary syndrome	2.45e-05	0.000175	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	2.45e-05	0.000175	CbGpPWpGaD
Bopindolol—ADRB2—GPCR downstream signaling—GNAS—polycystic ovary syndrome	2.44e-05	0.000175	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—ADRB2—polycystic ovary syndrome	2.43e-05	0.000174	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—SCT—polycystic ovary syndrome	2.42e-05	0.000174	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—AKR1C3—polycystic ovary syndrome	2.42e-05	0.000173	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—AKR1C1—polycystic ovary syndrome	2.39e-05	0.000172	CbGpPWpGaD
Bopindolol—HTR1A—GPCR downstream signaling—GNAS—polycystic ovary syndrome	2.39e-05	0.000171	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—TNRC6B—polycystic ovary syndrome	2.38e-05	0.000171	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—SCT—polycystic ovary syndrome	2.37e-05	0.00017	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	2.36e-05	0.000169	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—PGR—polycystic ovary syndrome	2.36e-05	0.000169	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—ADRB2—polycystic ovary syndrome	2.34e-05	0.000168	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—FGF18—polycystic ovary syndrome	2.32e-05	0.000166	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—MTNR1B—polycystic ovary syndrome	2.31e-05	0.000166	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—RBP4—polycystic ovary syndrome	2.3e-05	0.000165	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—FGF18—polycystic ovary syndrome	2.27e-05	0.000163	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—GNAS—polycystic ovary syndrome	2.27e-05	0.000163	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—MTNR1B—polycystic ovary syndrome	2.26e-05	0.000162	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—GNAS—polycystic ovary syndrome	2.26e-05	0.000162	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—RBP4—polycystic ovary syndrome	2.25e-05	0.000161	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—FGF18—polycystic ovary syndrome	2.22e-05	0.000159	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—GNAS—polycystic ovary syndrome	2.22e-05	0.000159	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—RBP4—polycystic ovary syndrome	2.2e-05	0.000158	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—GHRL—polycystic ovary syndrome	2.19e-05	0.000157	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—PLAT—polycystic ovary syndrome	2.19e-05	0.000157	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—GNAS—polycystic ovary syndrome	2.17e-05	0.000155	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—NCOR1—polycystic ovary syndrome	2.15e-05	0.000154	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—YAP1—polycystic ovary syndrome	2.15e-05	0.000154	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—GAB1—polycystic ovary syndrome	2.12e-05	0.000152	CbGpPWpGaD
Bopindolol—HTR1B—GPCR downstream signaling—POMC—polycystic ovary syndrome	2.11e-05	0.000151	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—NRG1—polycystic ovary syndrome	2.11e-05	0.000151	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—YAP1—polycystic ovary syndrome	2.1e-05	0.000151	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—ATF1—polycystic ovary syndrome	2.09e-05	0.00015	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—GAB1—polycystic ovary syndrome	2.07e-05	0.000149	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—YAP1—polycystic ovary syndrome	2.06e-05	0.000147	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—TCF7L2—polycystic ovary syndrome	2.04e-05	0.000146	CbGpPWpGaD
Bopindolol—HTR1B—GPCR downstream signaling—AKT2—polycystic ovary syndrome	2.03e-05	0.000145	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—GAB1—polycystic ovary syndrome	2.03e-05	0.000145	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—INSR—polycystic ovary syndrome	2.03e-05	0.000145	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—INSR—polycystic ovary syndrome	1.98e-05	0.000142	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—INSR—polycystic ovary syndrome	1.94e-05	0.000139	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—NGFR—polycystic ovary syndrome	1.93e-05	0.000138	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	1.93e-05	0.000138	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—POMC—polycystic ovary syndrome	1.92e-05	0.000137	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—PRL—polycystic ovary syndrome	1.91e-05	0.000137	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	1.9e-05	0.000136	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—AKR1C3—polycystic ovary syndrome	1.88e-05	0.000135	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—PGR—polycystic ovary syndrome	1.88e-05	0.000135	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—TNRC6B—polycystic ovary syndrome	1.85e-05	0.000133	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.84e-05	0.000132	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—AKR1C3—polycystic ovary syndrome	1.84e-05	0.000132	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—PGR—polycystic ovary syndrome	1.84e-05	0.000132	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.81e-05	0.00013	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	1.81e-05	0.00013	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—IRS2—polycystic ovary syndrome	1.81e-05	0.00013	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—PGR—polycystic ovary syndrome	1.8e-05	0.000129	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—LEP—polycystic ovary syndrome	1.77e-05	0.000127	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—GHRL—polycystic ovary syndrome	1.74e-05	0.000125	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—PLAT—polycystic ovary syndrome	1.74e-05	0.000125	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—PLAT—polycystic ovary syndrome	1.71e-05	0.000122	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—GHRL—polycystic ovary syndrome	1.71e-05	0.000122	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—GNAS—polycystic ovary syndrome	1.68e-05	0.000121	CbGpPWpGaD
Bopindolol—ADRB1—GPCR downstream signaling—POMC—polycystic ovary syndrome	1.68e-05	0.000121	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—GHRL—polycystic ovary syndrome	1.67e-05	0.00012	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—PLAT—polycystic ovary syndrome	1.67e-05	0.00012	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—ATF1—polycystic ovary syndrome	1.66e-05	0.000119	CbGpPWpGaD
Bopindolol—ADRB2—GPCR downstream signaling—POMC—polycystic ovary syndrome	1.64e-05	0.000118	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—ATF1—polycystic ovary syndrome	1.63e-05	0.000117	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.62e-05	0.000116	CbGpPWpGaD
Bopindolol—ADRB1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	1.62e-05	0.000116	CbGpPWpGaD
Bopindolol—HTR1A—GPCR downstream signaling—POMC—polycystic ovary syndrome	1.61e-05	0.000115	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.6e-05	0.000115	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—ATF1—polycystic ovary syndrome	1.59e-05	0.000114	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.59e-05	0.000114	CbGpPWpGaD
Bopindolol—ADRB2—GPCR downstream signaling—AKT2—polycystic ovary syndrome	1.58e-05	0.000113	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—IRS1—polycystic ovary syndrome	1.58e-05	0.000113	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—NRG1—polycystic ovary syndrome	1.57e-05	0.000113	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.55e-05	0.000111	CbGpPWpGaD
Bopindolol—HTR1A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	1.55e-05	0.000111	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—NGFR—polycystic ovary syndrome	1.54e-05	0.00011	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—POMC—polycystic ovary syndrome	1.53e-05	0.000109	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—PRL—polycystic ovary syndrome	1.52e-05	0.000109	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—POMC—polycystic ovary syndrome	1.52e-05	0.000109	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—INS—polycystic ovary syndrome	1.51e-05	0.000108	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—NGFR—polycystic ovary syndrome	1.5e-05	0.000108	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—POMC—polycystic ovary syndrome	1.49e-05	0.000107	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—PRL—polycystic ovary syndrome	1.49e-05	0.000107	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—NGFR—polycystic ovary syndrome	1.47e-05	0.000105	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.47e-05	0.000105	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—IGF1—polycystic ovary syndrome	1.46e-05	0.000105	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—AKT2—polycystic ovary syndrome	1.46e-05	0.000105	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—POMC—polycystic ovary syndrome	1.46e-05	0.000105	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—PRL—polycystic ovary syndrome	1.46e-05	0.000104	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.44e-05	0.000104	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.44e-05	0.000103	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.4e-05	0.000101	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.39e-05	9.95e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.38e-05	9.9e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—IRS2—polycystic ovary syndrome	1.35e-05	9.66e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—GNAS—polycystic ovary syndrome	1.34e-05	9.6e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—LEP—polycystic ovary syndrome	1.32e-05	9.45e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—GNAS—polycystic ovary syndrome	1.31e-05	9.39e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—GNAS—polycystic ovary syndrome	1.28e-05	9.18e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.28e-05	9.15e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—NRG1—polycystic ovary syndrome	1.25e-05	8.98e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.25e-05	8.95e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—NRG1—polycystic ovary syndrome	1.23e-05	8.78e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.22e-05	8.75e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—NRG1—polycystic ovary syndrome	1.2e-05	8.59e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—IRS1—polycystic ovary syndrome	1.18e-05	8.43e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—POMC—polycystic ovary syndrome	1.13e-05	8.12e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—INS—polycystic ovary syndrome	1.13e-05	8.07e-05	CbGpPWpGaD
Bopindolol—ADRB3—Signaling by GPCR—IL6—polycystic ovary syndrome	1.12e-05	8.01e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—IGF1—polycystic ovary syndrome	1.09e-05	7.81e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—AKT2—polycystic ovary syndrome	1.09e-05	7.8e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—IRS2—polycystic ovary syndrome	1.07e-05	7.69e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—LEP—polycystic ovary syndrome	1.05e-05	7.53e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—IRS2—polycystic ovary syndrome	1.05e-05	7.52e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.03e-05	7.42e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—LEP—polycystic ovary syndrome	1.03e-05	7.36e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—IRS2—polycystic ovary syndrome	1.03e-05	7.36e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—LEP—polycystic ovary syndrome	1e-05	7.2e-05	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—VEGFA—polycystic ovary syndrome	9.55e-06	6.84e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—IRS1—polycystic ovary syndrome	9.36e-06	6.71e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—IRS1—polycystic ovary syndrome	9.16e-06	6.57e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—POMC—polycystic ovary syndrome	9.02e-06	6.47e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—INS—polycystic ovary syndrome	8.97e-06	6.43e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—IRS1—polycystic ovary syndrome	8.96e-06	6.42e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—POMC—polycystic ovary syndrome	8.82e-06	6.32e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—INS—polycystic ovary syndrome	8.77e-06	6.29e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—IGF1—polycystic ovary syndrome	8.67e-06	6.22e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—AKT2—polycystic ovary syndrome	8.67e-06	6.21e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—POMC—polycystic ovary syndrome	8.63e-06	6.18e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—INS—polycystic ovary syndrome	8.58e-06	6.15e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—IGF1—polycystic ovary syndrome	8.49e-06	6.08e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—AKT2—polycystic ovary syndrome	8.48e-06	6.08e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—IL6—polycystic ovary syndrome	8.33e-06	5.97e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—IGF1—polycystic ovary syndrome	8.3e-06	5.95e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—AKT2—polycystic ovary syndrome	8.29e-06	5.94e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	8.24e-06	5.91e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	8.06e-06	5.78e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	7.88e-06	5.65e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—VEGFA—polycystic ovary syndrome	7.11e-06	5.1e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—IL6—polycystic ovary syndrome	6.63e-06	4.76e-05	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—IL6—polycystic ovary syndrome	6.6e-06	4.73e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—IL6—polycystic ovary syndrome	6.49e-06	4.65e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—IL6—polycystic ovary syndrome	6.34e-06	4.55e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—VEGFA—polycystic ovary syndrome	5.67e-06	4.06e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—VEGFA—polycystic ovary syndrome	5.54e-06	3.97e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—VEGFA—polycystic ovary syndrome	5.42e-06	3.89e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—IL6—polycystic ovary syndrome	4.92e-06	3.53e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—IL6—polycystic ovary syndrome	3.92e-06	2.81e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—IL6—polycystic ovary syndrome	3.83e-06	2.75e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—IL6—polycystic ovary syndrome	3.75e-06	2.69e-05	CbGpPWpGaD
